title: Nerve growth factor (NGF) has novel antidepressant-like properties in rats.
abstract: Nerve growth factor, a neurotrophin, may have other functions, including a role in depressive disorders. The present study sought to determine whether NGF would (1) have antidepressant-like effects and (2) behave similarly to or differently from other well-recognized antidepressants. Over a broad dose-range, NGF reduced the exaggerated swim test immobility exhibited by the Flinders Sensitive Line (FSL) rats, but at a standard dose of 40 ng/ml, it was not as effective as desipramine (DMI, 5 mg/kg). The low social interaction behavior and locomotor activity of the FSL rats were less affected by NGF than was the immobility. Acute treatment with NGF did not induce c-fos expression in brain regions known to be activated by other acute antidepressants. The fact that chronic treatment with DMI blunted the corticosterone response to fluoxetine was replicated in this study. However, chronic treatment with NGF did not alter this response. Similarly, chronic treatment with fluoxetine blunted 5-HT(1A) and 5-HT(2A) receptor-mediated responses, whereas chronic treatment with NGF was without effect. Thus, NGF has antidepressant-like effects but does not appear to have biochemical actions typical of other antidepressants.
authors: Department of Psychiatry, University of North Carolina at Chapel Hill, CB #7178, Chapel Hill, NC 27599-7178, USA. dhover@med.unc.edu
authors: David H
authors: DH
authors: Overstreet
authors: Kellie
authors: K
authors: Fredericks
authors: Darin
authors: D
authors: Knapp
authors: George
authors: G
authors: Breese
authors: John
authors: J
authors: McMichael
mesh_terms: D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D003891:Desipramine / Q000494:pharmacology; D004195:Disease Models, Animal; D004347:Drug Interactions; D005473:Fluoxetine / Q000494:pharmacology; D007035:Hypothermia; D009043:Motor Activity / Q000187:drug effects; D020932:Nerve Growth Factor / Q000494:pharmacology* / Q000627:therapeutic use; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018490:Serotonin Agents / Q000494:pharmacology; D012919:Social Behavior; D013550:Swimming
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D016760:Proto-Oncogene Proteins c-fos; D018490:Serotonin Agents; D005473:Fluoxetine; D020932:Nerve Growth Factor; D003891:Desipramine; D003345:Corticosterone